找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Smart City and Informatization; 7th International Co Guojun Wang,Abdulmotaleb El Saddik,Kim-Kwang Raymo Conference proceedings 2019 Springe

[复制链接]
楼主: Curator
发表于 2025-3-23 12:27:07 | 显示全部楼层
发表于 2025-3-23 15:54:50 | 显示全部楼层
Zhenping Qiang,Libo He,Fei Daiate and compare candidate radiopharmaceuticals, models that encompass the range of expected activity distributions in the tumor were examined to estimate the radiation-absorbed doses to tumor and to the tissues surrounding the tumor as a function of depth. These models were executed for the clinical
发表于 2025-3-23 19:24:41 | 显示全部楼层
Xiaolong Xu,Qi Wu,Chengxun He,Shaohua Wan,Lianyong Qi,Hao Wangroup of medicines bound by complex regulatory elements. Regulatory control of radiopharmaceuticals is primarily under two central federal agencies: the Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA). The principal role of the FDA is to regulate the safety and efficacy
发表于 2025-3-24 02:13:33 | 显示全部楼层
Weimin Li,Jinfang Sheng,Yikang Yan,Shaobo Zhang,Xingyu Deng,Wenxiu Huangons. In so doing, it will allow the reader to rapidly retrieve the information on indications and effectiveness that is required for optimal integration of these highly effective therapies into modern, complex treatment strategies...The renaissance in locoregional tumor therapies is an ongoing proce
发表于 2025-3-24 03:52:09 | 显示全部楼层
Hafiz ur Rahman,Guojun Wang,Md Zakirul Alam Bhuiyan,Jianer Chenide. In the United States, bronchogenic carcinoma is the second most common cancer for both men and women. In 2014, 224,210 new cases of bronchogenic carcinoma were diagnosed in the United States, and 154,900 people died of this disease, making bronchogenic carcinoma the leading cause of cancer-rela
发表于 2025-3-24 06:57:26 | 显示全部楼层
发表于 2025-3-24 12:39:58 | 显示全部楼层
发表于 2025-3-24 15:03:32 | 显示全部楼层
发表于 2025-3-24 22:47:52 | 显示全部楼层
Jing Chen,Wenjun Jiang into modern, complex treatment strategies.Fully reflects ad.This book presents, in condensed form, the clinical results achieved by means of various locoregional tumor therapies employed for different indications. In so doing, it will allow the reader to rapidly retrieve the information on indicati
发表于 2025-3-25 00:47:30 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 06:19
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表